CSPCY
Price
$4.12
Change
+$0.18 (+4.57%)
Updated
Jul 3 closing price
Capitalization
9.91B
DSNKY
Price
$22.25
Change
-$0.55 (-2.41%)
Updated
Jul 3 closing price
Capitalization
59.21B
Interact to see
Advertisement

CSPCY vs DSNKY

Header iconCSPCY vs DSNKY Comparison
Open Charts CSPCY vs DSNKYBanner chart's image
CSPC Pharmaceuticals Group
Price$4.12
Change+$0.18 (+4.57%)
Volume$21.94K
Capitalization9.91B
Daiichi Sankyo
Price$22.25
Change-$0.55 (-2.41%)
Volume$166.19K
Capitalization59.21B
CSPCY vs DSNKY Comparison Chart in %
Loading...
CSPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSPCY vs. DSNKY commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPCY is a Hold and DSNKY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CSPCY: $4.12 vs. DSNKY: $22.25)
Brand notoriety: CSPCY and DSNKY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CSPCY: 786% vs. DSNKY: 81%
Market capitalization -- CSPCY: $9.91B vs. DSNKY: $59.21B
CSPCY [@Pharmaceuticals: Major] is valued at $9.91B. DSNKY’s [@Pharmaceuticals: Major] market capitalization is $59.21B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPCY’s FA Score shows that 2 FA rating(s) are green whileDSNKY’s FA Score has 1 green FA rating(s).

  • CSPCY’s FA Score: 2 green, 3 red.
  • DSNKY’s FA Score: 1 green, 4 red.
According to our system of comparison, CSPCY is a better buy in the long-term than DSNKY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSPCY’s TA Score shows that 3 TA indicator(s) are bullish while DSNKY’s TA Score has 4 bullish TA indicator(s).

  • CSPCY’s TA Score: 3 bullish, 4 bearish.
  • DSNKY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CSPCY is a better buy in the short-term than DSNKY.

Price Growth

CSPCY (@Pharmaceuticals: Major) experienced а +2.50% price change this week, while DSNKY (@Pharmaceuticals: Major) price change was -3.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

DSNKY is expected to report earnings on Apr 25, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSNKY($59.2B) has a higher market cap than CSPCY($9.91B). DSNKY has higher P/E ratio than CSPCY: DSNKY (75.76) vs CSPCY (11.34). CSPCY YTD gains are higher at: 76.977 vs. DSNKY (-18.468). DSNKY has higher annual earnings (EBITDA): 203B vs. CSPCY (7.63B). DSNKY has higher revenues than CSPCY: DSNKY (1.28T) vs CSPCY (31.1B).
CSPCYDSNKYCSPCY / DSNKY
Capitalization9.91B59.2B17%
EBITDA7.63B203B4%
Gain YTD76.977-18.468-417%
P/E Ratio11.3475.7615%
Revenue31.1B1.28T2%
Total CashN/A825B-
Total DebtN/A143B-
FUNDAMENTALS RATINGS
CSPCY vs DSNKY: Fundamental Ratings
CSPCY
DSNKY
OUTLOOK RATING
1..100
7351
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
91
Overvalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
842
PRICE GROWTH RATING
1..100
3885
P/E GROWTH RATING
1..100
1398
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSPCY's Valuation (21) in the null industry is significantly better than the same rating for DSNKY (91). This means that CSPCY’s stock grew significantly faster than DSNKY’s over the last 12 months.

CSPCY's Profit vs Risk Rating (83) in the null industry is in the same range as DSNKY (100). This means that CSPCY’s stock grew similarly to DSNKY’s over the last 12 months.

DSNKY's SMR Rating (2) in the null industry is significantly better than the same rating for CSPCY (84). This means that DSNKY’s stock grew significantly faster than CSPCY’s over the last 12 months.

CSPCY's Price Growth Rating (38) in the null industry is somewhat better than the same rating for DSNKY (85). This means that CSPCY’s stock grew somewhat faster than DSNKY’s over the last 12 months.

CSPCY's P/E Growth Rating (13) in the null industry is significantly better than the same rating for DSNKY (98). This means that CSPCY’s stock grew significantly faster than DSNKY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSPCYDSNKY
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 11 days ago
72%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
71%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CSPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDIV92.320.70
+0.76%
First Trust NASDAQ Technology Div ETF
GYLD13.230.06
+0.48%
Arrow Dow Jones Global Yield ETF
FSMB19.930.02
+0.10%
First Trust Short Dur Mgd Muncpl ETF
RAAX31.80-0.02
-0.06%
VanEck Real Assets ETF
LDRT25.11-0.03
-0.14%
iShares iBonds 1-5 Year Treasury Ladder ETF

CSPCY and

Correlation & Price change

A.I.dvisor tells us that CSPCY and CHJTF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSPCY and CHJTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPCY
1D Price
Change %
CSPCY100%
+4.50%
CHJTF - CSPCY
23%
Poorly correlated
N/A
DSNKY - CSPCY
16%
Poorly correlated
-2.41%
BAYZF - CSPCY
12%
Poorly correlated
-0.90%
DSKYF - CSPCY
5%
Poorly correlated
-2.39%
CMOPF - CSPCY
4%
Poorly correlated
N/A
More

DSNKY and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSNKY has been loosely correlated with CHGCY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DSNKY jumps, then CHGCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSNKY
1D Price
Change %
DSNKY100%
-2.41%
CHGCY - DSNKY
38%
Loosely correlated
-0.89%
OTSKY - DSNKY
37%
Loosely correlated
-1.50%
DSKYF - DSNKY
34%
Loosely correlated
-2.39%
BIIB - DSNKY
23%
Poorly correlated
-0.24%
ALPMY - DSNKY
21%
Poorly correlated
-0.52%
More